BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//California Life Sciences - ECPv6.17.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.califesciences.org
X-WR-CALDESC:Events for California Life Sciences
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260826T160000
DTEND;TZID=America/Los_Angeles:20260826T190000
DTSTAMP:20260416T160059Z
CREATED:20260416T160059Z
LAST-MODIFIED:20260416T160059Z
UID:10001066-1787760000-1787770800@www.califesciences.org
SUMMARY:Beakers & Brews
DESCRIPTION:
URL:https://www.califesciences.org/event/beakers-brews-ssf-aug26/
LOCATION:Timber & Tide\, 685 Gateway Blvd\, South San Francisco\, CA\, 94080\, United States
CATEGORIES:California Life Sciences,Industry Collaboration & Networking,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2026/04/Beakers-Brews-SF-Web-Card-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260826T170000
DTEND;TZID=America/Los_Angeles:20260826T193000
DTSTAMP:20260803T161233Z
CREATED:20260803T161233Z
LAST-MODIFIED:20260803T161233Z
UID:10001142-1787763600-1787772600@www.califesciences.org
SUMMARY:Build or Buy?: Evaluating AI Vendors and Tools for Life Sciences
DESCRIPTION:This is a 90-minute session for life sciences professionals who keep ending up in vendor demos without the right questions to ask. We’ll cover the three categories of AI tools showing up in your field right now\, and the five questions that reveal what any vendor claim is actually saying and what it isn’t. \n​The session ends with a workshop: vendor pitches\, applied framework\, written output. You’ll leave knowing exactly what to ask the next time someone puts a demo in front of you. \n​No prior technical background needed. \n​Who this is for: Operation leads\, IT heads\, R&D professionals\, regulatory and clinical teams\, and anyone in life sciences who evaluates\, recommends\, or works alongside AI tools. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/evaluating-ai-vendors-and-tools-for-life-sciences/
LOCATION:Kilroy Oyster Point\, 357 Oyster Point Blvd\, South San Francisco\, CA\, 94080\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260827T083000
DTEND;TZID=America/Los_Angeles:20260827T130000
DTSTAMP:20260727T194001Z
CREATED:20260727T193946Z
LAST-MODIFIED:20260727T194001Z
UID:10001132-1787819400-1787835600@www.califesciences.org
SUMMARY:Advances in Neuropsychiatry: Emerging Biology and Therapeutics
DESCRIPTION:The Frontiers in Neuropsych Symposium is a fully virtual event highlighting the latest advances in novel neuroscience therapeutics. The symposium brings together experts from across the field to examine innovative approaches to complex neuropsychiatric disorders\, spanning early biological discovery through clinical development. \nDesigned for scientists\, clinicians\, and industry leaders\, the event provides a forum for discussing emerging research and therapies that address significant unmet needs and aim to improve patient outcomes worldwide. \nKey Topics:\n\nBiomarker- and genomics-guided drug discovery in schizophrenia\nMental illness and PTSD\nDevelopmental and rare disorders associated with psychosis\nSleep\, behavioral wellness\, and recovery\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/advances-in-neuropsychiatry-emerging-biology-and-therapeutics/
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/advances-in-neuropsychiatry-emerging-biology-and-therapeutics/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260827T120000
DTEND;TZID=America/Los_Angeles:20260827T130000
DTSTAMP:20260730T164058Z
CREATED:20260730T164058Z
LAST-MODIFIED:20260730T164058Z
UID:10001140-1787832000-1787835600@www.califesciences.org
SUMMARY:Genetically Engineered Mouse Models & Their Applications
DESCRIPTION:Genetically engineered mouse models (GEMMs) are the backbone of modern preclinical drug development. With the world’s largest GEMM repository and a fully integrated CRO platform\, GemPharmatech offers researchers an unmatched toolkit for moving from target biology to IND-enabling studies. \nIn this lunch and learn\, Jun Wang\, PhD\, Senior Scientific Director at GemPharmatech\, walks through real preclinical case studies across oncology\, metabolic disease\, neurology\, and immunology — illustrating how model selection\, study design\, and integrated CRO capabilities translate into more translatable data and more defensible go/no-go decisions. \nSpeaker Info\nJun Wang\, PhD \nSenior Scientific Director \nDr. Jun Wang has over 15 years of experience in biomedical research. Prior to joining GemPharmatech\, he served as an Associate Director of Research at Explora Biolabs/Charles River. He has extensive experience with genetically engineered mouse models for drug discovery in various therapeutic areas. Dr. Wang holds a Ph.D. in Developmental Neurobiology from the City of Hope and received his postdoctoral training in pediatric brain cancer research from the Sanford Burnham Prebys Medical Discovery Institute. \nAgenda\n\n​12:00 PM- 12:15 PM: Welcome – Lunch\n12:15- 1:00: Discussion\n​1:00 PM – 2:00 PM: Office Hours\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/genetically-engineered-mouse-models-their-applications/
LOCATION:5270 California Ave\, 5270 California Ave\, Irvine\, CA\, 92617\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260827T160000
DTEND;TZID=America/Los_Angeles:20260827T190000
DTSTAMP:20260416T160203Z
CREATED:20260416T160203Z
LAST-MODIFIED:20260416T160203Z
UID:10001067-1787846400-1787857200@www.califesciences.org
SUMMARY:Beakers & Brews
DESCRIPTION:
URL:https://www.califesciences.org/event/beakers-brews-sd-aug27/
LOCATION:CASA Campus Point\, 4242 Campus Point Ct\, San Diego\, CA\, 92121
CATEGORIES:California Life Sciences,Industry Collaboration & Networking,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2026/04/Beakers-Brews-SD-Web-Card.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260901
DTEND;VALUE=DATE:20260903
DTSTAMP:20260728T183123Z
CREATED:20260728T183123Z
LAST-MODIFIED:20260728T183123Z
UID:10001138-1788220800-1788393599@www.califesciences.org
SUMMARY:Hub and Specialty Pharmacy Models West
DESCRIPTION:The Hub and Specialty Pharmacy Model conference series returns to sunny San Diego\, CA at the stunning Estancia La Jolla Hotel & Spa. Demand for agile\, scalable and innovative programs are at an all time high as market dynamics continue to evolve and regulatory changes remains unclear. This event brings together top industry experts to equip you with cutting-edge technologies and actionable insights to enhance patient outcomes. Hub and Specialty Pharmacy Models West is the premier event for professionals seeking unparalleled networking opportunities and expert-driven content to refine their hub strategies and elevate their patient services suite. \n\nCLS members receive a 10% discount to attend the conference. Contact your account manager or reach out to bd@califesciences.org for more information. \n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/hub-and-specialty-pharmacy-models-west/
LOCATION:Estancia La Jolla Hotel & Spa\, 9700 N Torrey Pines Rd\, La Jolla\, 92037\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260902T070000
DTEND;TZID=America/Los_Angeles:20260902T080000
DTSTAMP:20260820T212048Z
CREATED:20260820T212048Z
LAST-MODIFIED:20260820T212048Z
UID:10001164-1788332400-1788336000@www.califesciences.org
SUMMARY:Accelerating Pre-Clinical Large-Molecule Screening with an Integrated DMPK/ADME Approach
DESCRIPTION:In early discovery and development\, accurate bioanalytical methods\, combined with CMC manufacturability\, are essential for driving molecule screening and assessing developability within a DMPK/ADME framework. \nIn this webinar\, BioDuro will present case studies spanning multiple novel modalities including antibodies\, bispecific antibodies\, ADC (Antibody Drug Conjugate)\, and APC (Antibody Peptide Conjugate) therapeutics. The presentation will focus on three key areas: \n\nLC-MS/MS\, ELISA\, and Gyrolab as comparable bioanalytical methods for ADC and antibody PK analysis\nTransgenic mouse PK as a rapid screening approach\nADME screening strategies for peptides\, linkers\, and payloads in ADC programs.\n\nThese case studies demonstrate how an integrated DMPK/ADME platform can accelerate preclinical screening and improve decision-making for early-stage large-molecule programs. While bioanalysis of biologics and conjugated therapeutics presents unique challenges due to matrix complexity\, molecular heterogeneity\, and evolving analytical requirements\, innovative bioanalytical strategies can generate robust\, reliable data that enable confident candidate selection and successful program progression. \nWhat you will learn: \n\nUnderstand the strengths and applications of LC-MS/MS\, ELISA\, and Gyrolab for consistent pharmacokinetic analysis of antibodies and ADC\nLearn how transgenic mouse pharmacokinetic models can serve as a rapid and efficient approach for early candidate screening\nExplore ADME screening strategies for peptides\, linkers\, and payloads to support the discovery and optimization of ADC programs\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/accelerating-pre-clinical-large-molecule-screening/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/accelerating-pre-clinical-large-molecule-screening/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260910T140000
DTEND;TZID=America/New_York:20260910T150000
DTSTAMP:20260820T211414Z
CREATED:20260820T211352Z
LAST-MODIFIED:20260820T211414Z
UID:10001162-1789048800-1789052400@www.califesciences.org
SUMMARY:The Insider's Guide to Leveraging Podcasts\, Webinars and Thought Leadership Programs
DESCRIPTION:How do you turn podcasts\, webinars and thought leadership programs into meaningful visibility for your organization or clients? \nJoin BioSpace’s Managing Editor\, Director of Insights and Vice President of Marketing for an inside look at how PR\, communications and marketing teams can successfully leverage webinars\, podcasts and integrated content campaigns to elevate executive voices\, share industry expertise and engage key biotech and pharma audiences. \nIn this interactive discussion\, our team will break down the differences between available thought leadership opportunities\, explain how content is selected and developed\, and share what makes a pitch stand out. You’ll gain practical guidance on identifying the right opportunities\, aligning topics with our audience interests\, preparing speakers for successful appearances and maximizing the value of participation before\, during and after an event. \nWhether you’re promoting an executive thought leader\, launching a new initiative or building long-term brand awareness\, you’ll walk away with actionable tips to help secure stronger opportunities and better outcomes. Attendees will also have the opportunity to ask questions during a live Q&A with the BioSpace editorial\, insights and marketing teams. \nWhat to expect: \n\nGain strong practical understanding of how BioSpace podcasts and webinars are developed\, produced and marketed\nGet an insider’s perspective on what makes a guest\, topic or pitch stand out to our team\nDiscover how to identify thought leadership opportunities that align with your marketing and communications goals\nLearn how to prepare executives for stronger\, more engaging appearances\nGet practical tips for extending the reach and impact of your content before\, during and after an event\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/insiders-guide-leveraging-thought-leadership-programs/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/insiders-guide-leveraging-thought-leadership-programs/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260910T170000
DTEND;TZID=America/Los_Angeles:20260910T190000
DTSTAMP:20260810T212922Z
CREATED:20260810T212922Z
LAST-MODIFIED:20260810T212922Z
UID:10001151-1789059600-1789066800@www.califesciences.org
SUMMARY:MedTech CEO Networking Reception
DESCRIPTION:Designed exclusively for manufacturing company CEOs and senior executives\, these intimate events provide an opportunity to briefly step away from day-to-day demands and engage with peers on the timely and relevant issues facing you and your company and shaping the future of our industry. \nWhat you’ll gain: \n\nConnect with fellow medtech leaders in a small\, invitation-only setting designed to foster candid conversations and valuable new relationships.\nHear unfiltered insights from industry CEOs as they discuss the opportunities\, challenges\, and strategic decisions keeping leadership teams focused today—from innovation and growth to policy\, investment\, talent\, board management\, the impact of AI and the evolving healthcare landscape.\nGet an exclusive and brief preview of The MedTech Conference\, including opportunities designed specifically for CEOs and executive leadership\, while helping shape the conversations that will continue in Boston this October.\n\nThe program will feature a discussion with: \n\nQuentin Blackford\, President & Chief Executive Officer\, iRhythm \nLisa Earnhardt\, EVP and Group President\, Medical Devices\, Abbott\nModerator: Philip Oettinger\, Partner\, Wilson Sonsini \n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/medtech-ceo-networking-reception/
LOCATION:Wilson Sonsini\, One Market Plaza Spear Tower\, 19th Floor\, San Francisco\, CA\, 94105\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260910T173000
DTEND;TZID=America/Los_Angeles:20260910T200000
DTSTAMP:20260803T161858Z
CREATED:20260803T161858Z
LAST-MODIFIED:20260803T161858Z
UID:10001144-1789061400-1789070400@www.califesciences.org
SUMMARY:How to Build a Working AI System in Life Sciences
DESCRIPTION:Everyone in life sciences has been told to use AI. Most have not been shown properly how. \n​Due to popular demand\, we’re hosting this session in person in SF. This is a 90-minute hands-on session for life sciences professionals who want to actually understand what AI systems do and leave having built one. \n​We’ll cover the mental model that makes everything else click: how AI systems process information\, why the tools you use behave the way they do\, and how to write instructions that produce reliable outputs. Then you’ll build a working assistant (and not agent – we’ll tell you why not) around a task from your own workflow. No coding experience required. \n​Bring a laptop\, your LLM of choice\, and one problem you’d like AI to help with. You’ll leave with something that works. \n​Who this is for: R&D professionals\, clinicians\, post-docs\, research scientists\, and anyone in life sciences who works with AI tools and wants to understand them better. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/build-ai-system-life-sciences-sf/
LOCATION:201 Third Street\, 201 Third Street\, San Francisco\, CA\, 94103\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260914
DTEND;VALUE=DATE:20260917
DTSTAMP:20260730T164423Z
CREATED:20260730T164423Z
LAST-MODIFIED:20260730T164423Z
UID:10001141-1789344000-1789603199@www.califesciences.org
SUMMARY:Biotech Symposium 2026
DESCRIPTION:The Charles River Biotech Symposium unites drug development professionals in an interactive setting to discuss the nonclinical development of biotherapeutics\, including regulatory issues and innovative approaches to problem-solving. The collegial spirit of this meeting creates exceptional opportunities for information sharing and networking. \nRegister today to save your seat for an event aimed to inspire\, educate\, and connect you with the opinion leaders shaping the future of biotherapeutics. Learn from their successes and failures\, how unexpected obstacles were overcome\, and hear stories of their interactions with the FDA. \nDon’t miss “Cross the Barrier: Targeted Tissue Delivery of Biologics” the optional workshop on Sunday\, September 13\, 2026 when making your travel plans. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/biotech-symposium-2026/
LOCATION:San Diego Mission Bay Resort\, 1775 East Mission Bay Drive\, San Diego\, CA\, 92109\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260915T093000
DTEND;TZID=America/Los_Angeles:20260915T103000
DTSTAMP:20260806T202448Z
CREATED:20260806T202448Z
LAST-MODIFIED:20260806T202448Z
UID:10001146-1789464600-1789468200@www.califesciences.org
SUMMARY:When Lyocakes Go Bad - How to Identify & Fix It
DESCRIPTION:Join our webinar to discover how you can identify and fix any issues in your own batches. Using different examples of lyocake defects\, Biopharma Group’s Senior Scientist\, Niloofar Ganji\, will explain how to identify these issues\, even when they’re not visible to the naked eye\, and share effective strategies for resolving them. \nThe session will cover key techniques such as Freeze Drying Microscopy (FDM) analysis and understanding collapse temperature\, helping you optimize primary drying conditions and prevent defects before they occur. \nKey Benefits of Attending\nYou’ll discover how to: \n\nIdentify & Classify Lyophilization Defects: Learn best practices for recognizing and naming various defects that can occur during freeze drying.\nUtilize Advanced Analytical Tools: Discover how to use instruments like MicroPress to detect defects that aren’t visible to the naked eye or reflected in standard performance assays.\nFix & Optimize: Understand how to rectify identified issues using cutting-edge tools like Lyostat5 and Lyotherm3 to pinpoint necessary process adjustments.\n\nand receive: \n\nReal-World Insights: Gain valuable takeaways from an in-depth case study demonstrating practical solutions.\nInteractive Q&A: Get your questions answered by an expert in the field.\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/when-lyocakes-go-bad-how-to-identify-fix-it/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/when-lyocakes-go-bad-how-to-identify-fix-it/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260915T100000
DTEND;TZID=America/Los_Angeles:20260915T110000
DTSTAMP:20260817T172045Z
CREATED:20260817T165621Z
LAST-MODIFIED:20260817T172045Z
UID:10001159-1789466400-1789470000@www.califesciences.org
SUMMARY:Exploring New Frontiers in In Vivo CAR-T Therapy
DESCRIPTION:Live Webinar: Exploring New Frontiers in In Vivo CAR-T Therapy \n📅 Date: Sept 15\, 2026\n🕙 Time: 10 AM PT | 1 PM ET | 5 PM GMT | 7 PM CET \nFeatured Talk 1: “Targeted-LNP Technology for Precision Genetic Medicine” – Joe Yu\, PhD\nThis talk will introduce practical strategies to overcome these bottlenecks and optimize tLNP development from early-stage discovery to scalable manufacturing. \nFeatured Talk 2: “From Delivery Vehicle to Cells: Enabling In Vivo CAR Development with Integrated End-to-End Solutions” – Hui Yu\, PhD\nExplore integrated solutions for targeted delivery\, LNP characterization\, and CAR detection to accelerate next-generation in vivo CAR therapy development. \n 
URL:https://www.califesciences.org/event/exploring-new-frontiers-in-in-vivo-car-t-therapy/
LOCATION:Virtual
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260915T110000
DTEND;TZID=America/Los_Angeles:20260915T120000
DTSTAMP:20260820T211046Z
CREATED:20260820T211046Z
LAST-MODIFIED:20260820T211046Z
UID:10001161-1789470000-1789473600@www.califesciences.org
SUMMARY:The Regulatory Foundation: Getting It Right Before You Build
DESCRIPTION:For early-stage MedTech founders\, regulatory strategy isn’t a late-stage checkbox\, it’s a foundational decision that shapes everything downstream\, from your FDA pathway to your funding story to how you eventually get paid. \nIn this fireside conversation\, former FDA reviewer Sam Murray walks through the decisions that matter most before you build. We’ll cover how your intended use and your own claims define your regulatory reality\, how to read your risk class and map the right pathway (510(k)\, De Novo\, or PMA)\, the low-cost early moves that get you FDA’s read before you’re locked in\, and what SBIR/STTR reviewers actually want to see in your commercialization plan. We’ll close with why regulatory and reimbursement timing should be planned together and how getting it right early is the cheapest course-correction there is. \nBring your questions for a live audience Q&A to wrap. \nREGISTER» \nAbout the Speakers\nSam Murray\, Head of Regulatory & Quality\, PRIA Healthcare\nSam leads PRIA’s regulatory affairs and quality division\, providing strategic leadership to life sciences and medical device companies navigating complex regulatory pathways and quality system challenges. He advises executive leadership teams\, investors and diligence teams\, product development organizations\, and regulatory and quality leaders on regulatory strategy\, global product approvals\, and scalable quality system design across the full product lifecycle. \nSam’s background spans medical devices\, diagnostics\, combination products\, and software-enabled technologies. His primary areas of expertise include U.S. regulatory strategy\, global regulatory submissions including European MDR and IVDR implementation\, quality system development and remediation\, design controls\, risk management\, and regulatory authority engagement. He has led and supported regulatory programs that enabled global marketing authorizations and reduced time to commercialization. In addition to founding and leading an independent regulatory and quality consultancy supporting medical device manufacturers globally\, Sam has also held senior leadership roles at Advanced Instruments and Formlabs\, where he built and scaled global regulatory and quality organizations\, established multi-site quality systems\, and led acquisition due diligence\, assessing regulatory risk\, quality system maturity\, and post-close integration needs. Sam previously served as a medical device investigator with the U.S. Food and Drug Administration\, conducting domestic and international inspections and driving compliance and enforcement actions. \n​Suzy Engwall\, Senior Director\, Global Business Development and Strategic Growth\, PRIA Healthcare\nSuzy is a healthcare innovation and commercialization executive\, who has spent nearly two decades helping MedTech companies navigate the complex journey from product development to market adoption. She has extensive experience across the MedTech ecosystem\, spanning startups\, accelerators\, health systems\, GPOs\, and international markets\, connecting clients with strategic guidance and expertise they need to successfully commercialize their technologies. \nBefore joining PRIA\, Suzy founded and led HealthTech Strategies\, a consulting firm specializing in U.S. market entry strategy\, GPO contracting\, and commercialization. She previously served as VP of Early MedTech Development at Alira Health\, advising emerging MedTech companies on clinical and commercial strategy. As National Director of the Innovation Lab at the Innovation Institute\, she managed a multi hospital innovation program that brought 21 products to market\, including licensing agreements with CVS and OrthoPediatrics. She designed and facilitated accelerator-style programming\, including hackathons\, innovation sprints\, and pitch showcases\, and guided participants through the process of refining\, patenting\, and launching their inventions. \nA recognized thought leader and speaker across the MedTech ecosystem\, Suzy has served as director and mentor for the Founder Institute HealthTech program\, was on advisory boards for ASU’s Edson College of Nursing and Health Innovation\, the UC Riverside Design Thinking Program\, and currently serves on multiple startup advisory boards\, including the Board of Directors of Actuated Medical. \nHosted by:
URL:https://www.califesciences.org/event/the-regulatory-foundation-university-lab-partners/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/the-regulatory-foundation-university-lab-partners/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260915T110000
DTEND;TZID=America/Los_Angeles:20260915T140000
DTSTAMP:20260727T194655Z
CREATED:20260727T194655Z
LAST-MODIFIED:20260727T194655Z
UID:10001133-1789470000-1789480800@www.califesciences.org
SUMMARY:Scientist.com's Vendor Discovery Day - San Francisco
DESCRIPTION:Join Scientist.com for our 2026 San Francisco Vendor Discovery Day and showcase your innovations! Connect with top researchers\, expand your network and elevate your brand’s visibility. Don’t miss this opportunity to unlock new collaborations and drive your business forward. See you in September! \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/scientist-coms-vendor-discovery-day-san-francisco/
LOCATION:685 Gateway Blvd\, 685 Gateway Blvd\, South San Francisco\, CA\, 94080
CATEGORIES:Industry Collaboration & Networking,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260916
DTEND;VALUE=DATE:20260918
DTSTAMP:20260603T233444Z
CREATED:20260603T233444Z
LAST-MODIFIED:20260603T233444Z
UID:10001097-1789516800-1789689599@www.califesciences.org
SUMMARY:Cell & Gene Therapy Symposium
DESCRIPTION:
URL:https://www.califesciences.org/event/cell-gene-therapy-symposium/
LOCATION:Salk Institute for Biological Studies\, 10010 N Torrey Pines Rd\, La Jolla\, CA\, 92037\, United States
CATEGORIES:California Life Sciences,Industry Collaboration & Networking,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2026/06/Cell-Gene-Therapy.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260916T080000
DTEND;TZID=America/Los_Angeles:20260916T090000
DTSTAMP:20260820T212315Z
CREATED:20260820T212315Z
LAST-MODIFIED:20260820T212315Z
UID:10001165-1789545600-1789549200@www.califesciences.org
SUMMARY:Regulatory Shifts Ahead: Preparing for FDA Changes and EU Pharmaceutical Reform
DESCRIPTION:Regulatory change is underway on two fronts. FDA review practice has evolved meaningfully over recent review cycles\, and the EU has finalized a sweeping reform of its pharmaceutical legislation that has not yet entered into force. For sponsors filing an IND with the FDA\, preparing an EMA submission\, or planning a Phase II expansion into the EU\, this session offers an early look at what’s changing and how to get ahead of it. \nIn this session\, William Lian (BioDuro) covers the current FDA IND landscape: where IND submission changes\, how Clinical Holds get resolved\, and why getting CMC right early is the key to avoiding them. William will also introduce FDA’s evolving expectations for nonclinical development\, including initiatives such as the increased use of New Approach Methodologies (NAMs). \nMiranda van Bodegom (DADA Consultancy) turns to the EU\, where the change is legal\, not procedural. She unpacks several developments under what EMA itself has called “the most significant overhaul of the regulatory framework in over two decades”. Miranda will introduce upcoming changes covering development and registration phases\, pharmacovigilance and regulatory aspects\, the new approach to environmental risk\, and the expanded the use of Master Files. \nJoin BioDuro and DADA Consultancy to find out what’s changing\, and what sponsors should be preparing for. \nWhat you will learn: \n\nWhy FDA Clinical Holds happen\, and how CMC readiness prevents them\nWhether FDA’s NAMs shift changes your preclinical testing plan\nWhether you qualify for a Master File under the EU’s pharmaceutical legislation reform\nHow to navigate the European “green legislation”\nHow to position your pipeline now\, ahead of these changes taking full effect\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/preparing-for-fda-changes-and-eu-pharmaceutical-reform/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/preparing-for-fda-changes-and-eu-pharmaceutical-reform/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260917T080000
DTEND;TZID=America/Los_Angeles:20260918T170000
DTSTAMP:20260625T182515Z
CREATED:20260625T182515Z
LAST-MODIFIED:20260625T182515Z
UID:10001115-1789632000-1789750800@www.califesciences.org
SUMMARY:PCC West | Pharmaceutical Compliance Congress West
DESCRIPTION:Transform your compliance strategy at PCC West – the West Coast’s most dynamic gathering of life science compliance leaders. This September 10-11 at Hilton La Jolla in San Diego\, immerse yourself in cutting-edge insights that will revolutionize how you navigate today’s complex regulatory landscape. Discover game-changing strategies for FDA compliance\, master DOJ enforcement trends\, and unlock the potential of AI while mitigating risks. Engage with visionary experts tackling real-world challenges in HCP engagement\, patient interactions\, and program optimization. You’ll leave equipped with actionable intelligence and powerful connections that elevate your compliance program from reactive to revolutionary. \n\nCLS members receive a 10% discount on registration for the event. Contact your account manager or reach out to bd@califesciences.org for more information. \n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/pcc-west-2026/
LOCATION:HILTON LA JOLLA TORREY PINES\, 10950 N. Torrey Pines Road\, La Jolla\, CA\, 92037\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260922
DTEND;VALUE=DATE:20260924
DTSTAMP:20260727T203342Z
CREATED:20260727T203342Z
LAST-MODIFIED:20260727T203342Z
UID:10001137-1790035200-1790207999@www.califesciences.org
SUMMARY:RESI Boston 2026
DESCRIPTION:RESI Boston 2026\, a key component of Biotech Week Boston\, will take place on September 22-23 at the Westin Copley Place\, followed by three days of virtual partnering on September 25\,28-29. This hybrid format combines the benefits of in-person networking with the flexibility of online interactions. \n\nThrough August 14\, the California Life Sciences community can save an additional $200 on RESI Boston registration. Contact your account manager or reach out to bd@califesciences.org for more information. \n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/resi-boston-2026/
LOCATION:Westin Copley Place\, 10 Huntington Ave\, Boston\, CA\, 02116\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2026/02/Beyond-California-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260922T120000
DTEND;TZID=America/Los_Angeles:20260922T160000
DTSTAMP:20260817T172155Z
CREATED:20260817T165348Z
LAST-MODIFIED:20260817T172155Z
UID:10001158-1790078400-1790092800@www.califesciences.org
SUMMARY:Discovery Bites 2026: Structural Biology in the Age of AI
DESCRIPTION:Discovery Bites 2026 is an invitation-based working lunch hosted by IRBM during Biotech Week Boston\, held inside the Harvard Art Museums. \nTopic: Structural Biology in the Age of AI. The Power of NMR Experimental Data for Smarter Drug Discovery. \nAI-driven drug discovery is only as powerful as the data behind it. As AI and structure prediction tools reshape the field\, NMR remains a uniquely powerful technique for revealing molecular insights that no other method can match. Alessandro Piai\, PhD MBA\, Head of Structural Biology at IRBM\, will speak for around 45 minutes before opening the floor to questions and discussion. \nProgram: 12:00 pm arrival and lunch\, 1:00 pm presentation\, 1:45 pm Q&A\, 2:00 pm networking.\nGuests are then welcome to explore the museum galleries. \nWho should attend: research leaders accountable for go/no-go decisions on lead and candidate series\, structural biologists and biophysicists prioritizing limited instrument time\, and CSOs\, founders and R&D executives assessing whether structural work is mission-critical. \nThere is no fee to attend. Places are limited and confirmed on a rolling basis. Registration closes September 4\, 2026. \nREGISTER \nContact: Michael Ziebell\, PhD\, Assoc. Director Business Development\, m.ziebell@irbm.com\, +1 781 579 0436.
URL:https://www.califesciences.org/event/discovery-bites-2026-structural-biology-in-the-age-of-ai/
LOCATION:Harvard Art Museum\, 32 Quincy St\, Cambridge\, MA\, 02138
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2026/02/Beyond-California-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260928T084500
DTEND;TZID=America/Los_Angeles:20260928T163000
DTSTAMP:20260817T171524Z
CREATED:20260817T163834Z
LAST-MODIFIED:20260817T171524Z
UID:10001155-1790585100-1790613000@www.califesciences.org
SUMMARY:Nonclinical safety pharmacology studies for IND and regulatory filings
DESCRIPTION:This workshop will provide an integrated overview of how safety pharmacology studies support IND‑enabling development\, with a focus on regulatory expectations\, evolving scientific practices\, and translational decision‑making. Topics will begin with an overview of current regulatory guidance and agency expectations for safety pharmacology programs\, setting the framework for study scope\, timing\, and interpretation. \nCore systems safety pharmacology will be addressed in depth\, including nonclinical cardiovascular (CV) safety assessment\, with discussion of study design\, endpoints\, and integration with clinical risk assessment. This will be complemented by a clinical pharmacology perspective on CV safety\, including TQT studies\, criteria for TQT waivers\, and strategies for leveraging nonclinical and early clinical data to support regulatory decisions. \nCentral nervous system (CNS) safety will be covered through focused discussions on seizure liability\, the use of EEGs\, and interpretation of neurophysiologic signals in both discovery and IND‑enabling contexts. Respiratory safety pharmacology will be reviewed\, highlighting standard approaches\, key endpoints\, and relevance to human risk. \nBroader safety pharmacology considerations beyond the core battery will be discussed\, including evaluation of CNS\, brain\, gastrointestinal\, renal\, and related organ system effects\, with emphasis on fit‑for‑purpose study design and data integration. The workshop will conclude with emerging approaches\, featuring novel safety pharmacology studies that have elucidated Nav1.7‑associated dysautonomia\, illustrating how targeted mechanistic assessments can inform clinical safety and enhance translational understanding. \nREGISTER
URL:https://www.califesciences.org/event/nonclinical-safety-pharmacology-studies-for-ind-and-regulatory-filings/
LOCATION:1221 Chess Drive\, 1221 Chess Dr\, Foster City\, CA\, 94404
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260928T110000
DTEND;TZID=America/Los_Angeles:20260928T130000
DTSTAMP:20260706T155445Z
CREATED:20260706T155445Z
LAST-MODIFIED:20260706T155445Z
UID:10001120-1790593200-1790600400@www.califesciences.org
SUMMARY:The Endpoints 11: biopharma’s most promising startups in 2026
DESCRIPTION:True innovation has never been harder to see. \nNew financial models are changing how and where new drugs get developed. Promising molecules draw a dozen copycats right out the gate. The genuinely risky\, boundary-pushing work often happens behind closed doors. \nEndpoints editors sifted through the muddle to uncover eleven companies whose work clears the bar. These are the groups building the tools and making the scientific advances that help the industry take leaps forward. \nEndpoints 11 is more than a list. It’s a night where founders\, investors and the editors who follow them come together in one room. \nThe Endpoints 11 virtual experience\nWatch the highlights from the gala’s fireside chat and editorial introductions\, then go deeper with winner interviews and conversations with the Endpoints editors behind the selections. Free to register. \nAgenda to be announced.\nThe virtual day brings you inside the story: winner interviews\, bonus content\, and conversations with the Endpoints editors who selected this year’s cohort. \nWant to be in the room for the unveiling? Reserve your spot for the in-person gala dinner. \nThe gala is in-person only\, and intentionally intimate. Held at the iconic State Room in Boston\, it’s where you’ll hear from the 11 companies first\, then spend the evening in conversation with the founders building them\, the investors backing them and the journalists who chose them. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/the-endpoints-11-2026/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/the-endpoints-11-2026/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260929T083000
DTEND;TZID=America/Los_Angeles:20261001T151500
DTSTAMP:20260806T202132Z
CREATED:20260806T202111Z
LAST-MODIFIED:20260806T202132Z
UID:10001145-1790670600-1790867700@www.califesciences.org
SUMMARY:Lyophilization Technology Training Workshop: Product\, Process & Systems
DESCRIPTION:Held at UMass Lowell (MA) this 3-day lyophilization technology workshop running from September 29th to October 1st\, 2026\, gives participants a practical and structured overview of the lyophilization process\, from product characterization and formulation considerations through to cycle development\, scale-up and freeze-dryer systems. \nLed by experts in the field of lyophilization from Biopharma Group\, attendees will cover the science\, best practices and engineering behind lyophilization. Through a combination of theoretical sessions and practical workshops\, participants will explore how these principles can be applied to real-life lyo cycle and development questions. \nWhat you’ll learn:\n\nUnderstand the science and best practices behind the lyophilization process\nExplore product characterization methods used before lyophilization cycle development\nReview formulation design strategies for stable lyophilized products\nUnderstand freezing\, primary drying and secondary drying principles\nLearn key considerations for cycle development\, loading and scale-up\nExplore process monitoring\, PAT\, QbD and software-based development approaches\nUnderstand refrigeration\, vacuum\, stoppering and process condenser systems\nEvaluate lyophile appearance\, product analysis\, maintenance and troubleshooting considerations\n\nWhy this course?\nTaught by Dr Kevin Ward and Andrew Ray – Kevin is Biopharma Group’s Director of R&D and has worked in lyophilization since 1993. Andrew is Engineering Manager\, specialising in freeze dryer service\, repair\, installation\, validation and engineering training. \n\nSmall group format with direct access to expert instruction\nCombines lyophilization science\, best practice and engineering knowledge\nCovers product\, process and freeze-dryer system considerations\nIncludes practical workshops and multidisciplinary group exercises\nApplies learning to real-life lyo cycle and development questions\nCertificate of completion provided upon successful completion\n\nWho should attend?\n\nProfessionals working in pharma\, biopharma\, diagnostics\, medical and biotechnology settings\nScientists and engineers using lyophilization from R&D through to manufacturing\nR&D and formulation scientists developing or supporting lyophilized products\nLab managers and technicians involved in freeze-drying processes and analysis\nProduction operatives supporting lyophilization in manufacturing environments\nEngineers and technical support teams working with freeze-dryer systems\nQuality assurance teams supporting product quality and process control\nAnyone seeking a broader understanding of product\, process and system considerations\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/lyophilization-workshop-lowell/
LOCATION:UMass Lowell North Campus\, SAAB Emerging Technology & Innovation Centre (ETIC)\, 40 University Avenue\, Lowell\, MA\, 01854\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2026/02/Beyond-California-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260929T100000
DTEND;TZID=America/Los_Angeles:20260929T200000
DTSTAMP:20260817T172215Z
CREATED:20260817T165119Z
LAST-MODIFIED:20260817T172215Z
UID:10001157-1790676000-1790712000@www.califesciences.org
SUMMARY:BioscienceLA Week Investor & Innovation Day
DESCRIPTION:Attendees will gain a deeper understanding of the advantages of investing in the Los Angeles bioscience ecosystem\, along with insights into how bioscience companies have successfully navigated the various stages of investment funding. \nThe program will highlight the region’s unique opportunities for private and corporate investors while exploring the resources\, partnerships\, and capital landscape driving innovation. Target attendees include private and institutional investors\, early-stage bioscience companies\, entrepreneurs\, and industry stakeholders. \nREGISTER
URL:https://www.califesciences.org/event/biosciencela-week-investor-innovation-day/
LOCATION:8687 Melrose Ave\, 8687 Melrose Ave\, West Hollywood\, CA\, 90069
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260929T110000
DTEND;TZID=America/New_York:20260929T120000
DTSTAMP:20260820T211647Z
CREATED:20260820T211647Z
LAST-MODIFIED:20260820T211647Z
UID:10001163-1790679600-1790683200@www.califesciences.org
SUMMARY:From Facility to Delivery: Solving the Complex Science of ADC Linker-Payload Synthesis
DESCRIPTION:The rapid growth of antibody-drug conjugate (ADC) programs is creating new challenges for a CDMO execution for highly potent linker-payloads. While containment\, limited material availability\, and accelerated timelines are well-recognized challenges\, successful scale-up and GMP manufacture often depend on solving less frequently discussed problems. These include establishing reference standards when only small quantities of material are available\, managing unusual solubility and physical properties associated with increasingly complex and high-molecular-weight linker-payloads\, establishing industrial hygiene and cleaning limits\, and introducing equipment capable of safely handling highly potent materials without compromising development flexibility or product recovery. \nIn this webinar\, experts from SK pharmteco’s European and North American sites will share practical experience addressing these challenges across the linker-payload development lifecycle—from facility and containment strategy through process and analytical development\, scale-up\, cleaning\, and final product release. Case-based examples will illustrate how integrated chemistry\, engineering\, analytical\, and industrial hygiene strategies can reduce technical risk and support the rapid transition of emerging ADC programs into GMP manufacturing. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/facility-to-delivery-adc-linker-payload-synthesis/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/facility-to-delivery-adc-linker-payload-synthesis/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20261006T160000
DTEND;TZID=America/Los_Angeles:20261006T190000
DTSTAMP:20260810T223536Z
CREATED:20260810T223536Z
LAST-MODIFIED:20260810T223536Z
UID:10001152-1791302400-1791313200@www.califesciences.org
SUMMARY:Science on Tap
DESCRIPTION:Join us on October 6 from 4:00 to 7:00 p.m. for Science on Tap\, presented in partnership with Lonza. Enjoy a panel discussion and dedicated networking with biotech entrepreneurs\, biopharmaceutical leaders\, and investors. Whether you’re driving early-stage innovation or seeking new collaboration opportunities\, this is your chance to connect with peers\, partners\, and thought leaders in a focused yet relaxed setting. \nPlease check back soon for registration details. \nHosted in Partnership with:
URL:https://www.califesciences.org/event/science-on-tap/
LOCATION:Timber & Tide\, 685 Gateway Blvd\, South San Francisco\, CA\, 94080\, United States
CATEGORIES:California Life Sciences,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2026/08/10.06-Science-on-Tap.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20261010T083000
DTEND;TZID=America/Los_Angeles:20261010T170000
DTSTAMP:20260629T182735Z
CREATED:20260629T182735Z
LAST-MODIFIED:20260629T182735Z
UID:10001118-1791621000-1791651600@www.califesciences.org
SUMMARY:Scripps Research Biotech Innovation Summit
DESCRIPTION:In its third year\, the Scripps Research Biotech Research Summit aims to foster strategic partnerships between academia and industry and accelerate innovation across the biotech spectrum. \nUnder the guidance of the Strategic Investment Committee\, this year’s program includes engaging sessions focused on empowering scientific talent and forging meaningful connections. This event provides an exclusive opportunity to engage with world-class scientists who are pioneering exciting early-stage innovations. \n\nKeynote presentation on the future of AI-enabled drug discovery and translational science\nPerspectives from industry leaders advancing AI-driven therapeutics\nScripps Research faculty presentations showcasing cutting-edge innovation and technologies available for partnering\nOpportunities for networking with investors\, industry executives\, entrepreneurs\, and researchers\nInteractive sessions connecting attendees with scientific and business leaders\n\nWe look forward to seeing you there! \nREGISTER»
URL:https://www.califesciences.org/event/scripps-research-biotech-innovation-summit/
LOCATION:10620 John Jay Hopkins Dr\, 10620 John Jay Hopkins Dr\, San Diego\, CA\, 92121\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20261014T080000
DTEND;TZID=America/Los_Angeles:20261014T190000
DTSTAMP:20260806T205904Z
CREATED:20260806T205904Z
LAST-MODIFIED:20260806T205904Z
UID:10001150-1791964800-1792004400@www.califesciences.org
SUMMARY:2026 BioTools Innovator Capstone
DESCRIPTION:The BioTools Innovator Capstone brings together leaders from biotech\, pharma\, life science tools\, and the investment community to celebrate the innovations reshaping how medicine is discovered\, developed\, and delivered. Hosted at UCSD Park & Market in San Diego\, the full-day event features curated programming across startup showcases\, expert panels\, and all-day partnering — connecting 200+ investors\, industry leaders\, and strategic partners with the entrepreneurs building the infrastructure of tomorrow’s medicine. \nThe Capstone culminates in the BTI Finals Competition\, where top companies from the 2026 cohort make their case to a room of leading life science investors and industry decision-makers\, and compete for the top prize of $250\,000. Together\, the day’s programming celebrates the tools and platforms redefining how science gets done — and the founders determined to bring them to market. \n\nCLS members receive a 15% discount to attend the full day of startup showcases\, expert panels\, and all-day partnering. Be sure to select “CLS” when asked “How did you hear about the BTI Capstone?” on the form. \n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/2026-biotools-innovator-capstone/
LOCATION:UC San Diego Park & Market\, 1100 Market St\, San Diego\, CA\, 92101\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261018
DTEND;VALUE=DATE:20261022
DTSTAMP:20260727T195947Z
CREATED:20260727T195947Z
LAST-MODIFIED:20260727T195947Z
UID:10001136-1792281600-1792627199@www.califesciences.org
SUMMARY:The MedTech Conference
DESCRIPTION:This October 18-21\, the global medtech community will come together in Boston\, Massachusetts\, for four days of connection\, insight\, and momentum. The MedTech Conference will convene leaders from across the medtech ecosystem—all in one place—to exchange ideas\, showcase innovation\, and shape what’s next for health care. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/the-medtech-conference/
LOCATION:Boston Convention & Exhibition Center\, 415 Summer Street\, Boston\, CA\, 02210\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2026/02/Beyond-California-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261028
DTEND;VALUE=DATE:20261030
DTSTAMP:20260729T155030Z
CREATED:20260729T155030Z
LAST-MODIFIED:20260729T155030Z
UID:10001139-1793145600-1793318399@www.califesciences.org
SUMMARY:Future Labs Live USA
DESCRIPTION:Future Labs Live USA 2026 is America’s leading lab technology marketplace\, taking place October 28–29 at the Pennsylvania Convention Center\, Philadelphia. Defined by the theme “Digital. Automated. Connected.”\, it serves as a central hub for laboratory innovation. \n\nAudience: Connects 2\,000+ VIP decision-makers from sectors including pharma\, biotech\, chemicals\, and FMCG.\nMarketplace: Features 150+ exhibitors and startups providing live technology demonstrations on the show floor.\nConference: Offers a FREE program with 100+ speakers covering eight key themes\, including AI\, robotics\, data management\, and sustainability.\nNetworking: Facilitates partnerships through a dedicated 1-2-1 meeting zone\, interactive roundtables\, and social sessions.\n\n\nCLS members receive a 20% discount on premium networking passes and exhibition opportunities. Contact your account manager or reach out to bd@califesciences.org for more information. \n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/future-labs-live-usa-2026/
LOCATION:Pennsylvania Convention Center\, Grand Hall 1111 Market Street\, Philadelphia\, PA\, 19107\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2026/02/Beyond-California-Industry-Event.png
END:VEVENT
END:VCALENDAR